/VYYRF
VYYRF Stock - Voyageur Pharmaceuticals Ltd.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.10+0.00%
+$0.00 (+0.00%) • Dec 19
56
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.20
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.84
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.11
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for VYYRF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.10 – $0.10
TARGET (TP)$0.11
STOP LOSS$0.09
RISK/REWARD1:1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.90
52W High$0.25
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | $-2,185 | $-2,908 | $-2,246 | $-1,483 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-1,513 | $-1,220,952 | $-1,749,956 | $-1,972,009 | $-848,939 |
| Net Income | $-1,707 | $-1,399,469 | $-1,753,894 | $-2,051,467 | $-1,139,422 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.01 | $-0.01 | $-0.02 | $-0.02 | $-0.02 |
Company Overview
Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. The company intends to develop barium and iodine radiocontrast products and bromine based pharmaceutical products. It holds 100% interest in three barium sulfate deposits, including two properties suitable in grade for the pharmaceutical barite marketplace located in British Columbia, Canada; and interests in a high-grade iodine, lithium, and bromine brine project in Utah, the United States. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
VYYRFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q4 2024
EPS Surprise History
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q4 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Oct 27, 2025 | — | — | — | — |
Q2 2025 | Apr 25, 2025 | — | — | — | — |
Q4 2024 | Nov 30, 2024 | — | $-0.00 | — | — |
Q3 2024 | Aug 30, 2024 | — | $-0.00 | — | — |
Q2 2024 | May 30, 2024 | — | $-0.00 | — | — |
Q1 2024 | Feb 29, 2024 | — | $-0.00 | — | — |
Q4 2023 | Nov 30, 2023 | — | $-0.00 | — | — |
Q3 2023 | Aug 31, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 31, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 30, 2023 | — | $-0.00 | — | — |
Q1 2023 | Feb 28, 2023 | — | $-0.00 | — | — |
Q4 2022 | Oct 31, 2022 | — | $-0.00 | — | — |
Q3 2022 | Aug 1, 2022 | — | $-0.00 | — | — |
Q2 2022 | Apr 29, 2022 | — | $-0.00 | — | — |
Q1 2022 | Mar 17, 2022 | — | $-0.01 | — | — |
Q4 2021 | Oct 28, 2021 | — | $-0.00 | — | — |
Q3 2021 | Jul 26, 2021 | — | $-0.00 | — | — |
Q2 2021 | Apr 28, 2021 | — | $-0.00 | — | — |
Q1 2021 | Mar 30, 2021 | — | $-0.00 | — | — |
Q4 2020 | Oct 30, 2020 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about VYYRF
What is VYYRF's current stock price?
Voyageur Pharmaceuticals Ltd. (VYYRF) is currently trading at $0.10 per share. The stock has moved +0.00% today.
What is the analyst price target for VYYRF?
No analyst price targets are currently available for this stock.
What sector is Voyageur Pharmaceuticals Ltd. in?
Voyageur Pharmaceuticals Ltd. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is VYYRF's market cap?
Voyageur Pharmaceuticals Ltd. has a market capitalization of $0.02 billion, making it a small-cap company.
Does VYYRF pay dividends?
No, Voyageur Pharmaceuticals Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAVCNF
Avicanna Inc.
$0.17
Mkt Cap: $0.0B
CAAOF
INDVR Brands Inc.
$0.00
Mkt Cap: $0.0B
CNTMF
Fluent Corp.
$0.06
Mkt Cap: $0.0B
CWBHF
Charlotte's Web Holdings, Inc.
$0.21
Mkt Cap: $0.0B
GBLP
Global Pharmatech, Inc.
$0.05
Mkt Cap: $0.0B
ISCNF
Isracann Biosciences Inc.
$0.00
Mkt Cap: $0.0B
IZOZF
Izotropic Corporation
$0.21
Mkt Cap: $0.0B
MEDIF
MediPharm Labs Corp.
$0.05
Mkt Cap: $0.0B
RAPH
Raphael Pharmaceutical Inc.
$1.40
Mkt Cap: $0.0B
ROMJF
Rubicon Organics Inc.
$0.36
Mkt Cap: $0.0B
Explore stocks similar to VYYRF for comparison